Ownes & Minor (OMI) Declares $0.2575 Quarterly Dividend; 4.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Ownes & Minor (OMI) Misses Q3 EPS by 10c; Lowers Outlook
November 1, 2017 7:05 AM EDTOwnes & Minor (NYSE: OMI) reported Q3 EPS of $0.40, $0.10 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.4 billion.
GUIDANCE:
Ownes & Minor sees FY2017 EPS of $1.75-$1.85, versus the consensus of... More
Halyard Health (HYH) to Sell S&IP Business to Owens & Minor (OMI) for $710M
November 1, 2017 7:03 AM EDTHalyard Health, Inc. (NYSE: HYH) today announced it has entered into a definitive agreement with Owens & Minor, Inc. (NYSE: OMI) to sell its Surgical and Infection Prevention ("S&IP") business for $710 million. S&IP provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
The divestiture of the S&IP business accelerates Halyard's transformation into a pure-play medical devices business, with market leading positions in its core franchises of pain management and chronic care. As a growth-oriented business with a singular focus... More



